Boston Partners Acquires 216,210 Shares of Haemonetics Co. (NYSE:HAE)
Boston Partners lifted its holdings in shares of Haemonetics Co. (NYSE:HAE – Get Rating) by 72.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 516,224 shares of the medical instruments supplier’s stock after buying an additional 216,210 shares during the quarter. Boston […]